Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)
Clinical trial NCT00562640 · COMPLETED
Trial details
- NCT number
- NCT00562640
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-16
- Primary completion
- 2021-08-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.